Most pharmacogenomic tests include the DPYD gene. This gene affects the ability to process certain chemotherapies that are commonly used in treating colorectal cancer, metastatic breast cancer and others. It is estimated that about 1300 people die each year in the US because they are given 5-fluorouracil or capecitabine without being properly tested first. In […]